News | September 19, 2014

2014 Breast Cancer Symposium Highlighted Research Advances in Prevention, Screening, Therapy

September 19, 2014 — Five presentations from the 2014 Breast Cancer Symposium in San Francisco earlier this month focused on new studies exploring preventive mastectomy, compliance with recommended screening mammography and risk of recurrence after pre-surgery therapy for breast cancer.

Some brief summaries:

Angelina Jolie's Story May Have Helped Double BRCA Testing Rates at a Canadian Cancer Center: A new study shows that Angelina Jolie's public announcement and resulting media coverage of her decision to undergo a preventive mastectomy due to her BRCA mutation status likely drove an almost doubling of genetic referrals, testing and detection of BRCA mutation carriers at a Canadian academic center over a six-month period.

Breast Cancer Surgery and Reconstruction Complications Are Rare, Though Double Mastectomy Has Higher Risk of Certain Complications Compared to Single Mastectomy: A large study assessing 30-day complications after breast surgery with reconstruction in more than 18,000 women with breast cancer found that complications from either bilateral or unilateral mastectomy with reconstruction are infrequent, but women who undergo the bilateral procedure have higher rates of implant loss and need for transfusion, and typically have a longer hospital stay.

Survey Reveals Factors Influencing Women to Consider Preventive Double Mastectomy: A survey conducted among 150 women newly diagnosed with breast cancer at two Chicago hospitals finds that women who opted for contralateral prophylactic mastectomy tended to have higher levels of anxiety but less knowledge about the actual likelihood of breast cancer recurrence compared to women who did not consider or want the procedure.

A Simple Intervention Improves Return Rates for Women Overdue for Screening Mammography: A large Canadian study found that simply adding a letter signed by the primary care doctor to standard postcard reminders increased the odds of a women returning for mammogram screening.

Response to Neoadjuvant Chemotherapy and Tumor Subtype Are Strong Predictors of Loco-regional Breast Cancer Recurrence: A large study provided new insight on the factors affecting loco-regional breast cancer recurrence in women treated with chemotherapy before surgery. The findings could help to better identify women who may benefit from receiving radiotherapy after surgery to reduce the risk of recurrence.

"Understanding what motivates our patients to get testing or make treatment choices is critical to us as oncologists for providing the highest quality of care," said Harold Burstein, M.D., Ph.D., from the Dana-Farber Cancer Institute in Boston. "The studies featured today provide crucial insight into patient decision-making and advance our knowledge of post-treatment risk of recurrence and complications."

For more information: www.breastcasym.org

Related Content

Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits
News | Breast Density | February 20, 2019
The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D.,...
Congress Directs FDA to Establish Federal Breast Density Inform Standard
News | Breast Density | February 19, 2019 | Jeff Zagoudis, Associate Editor
As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to...
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
 Volpara Solutions Launches Next-Generation VolparaDensity Software to Support SmartCurve Paddles
Technology | Breast Density | January 31, 2019
Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in...
QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids
News | Ultrasound Women's Health | January 30, 2019
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission
Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Feature | Breast Imaging | January 30, 2019 | By Jeff Zagoudis
The importance of early detection of...